Olimel N7e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N7e provides a source of amino acids that act on protein metabolism pathways, useful in several clinical nutrition contexts.

• Post‑operative recovery: Helps maintain nitrogen balance and supports tissue repair.
• Chronic kidney disease management: Provides a controlled amino acid profile to reduce uremic toxin accumulation.
• Inherited metabolic disorders: Supplies specific amino acids required in conditions such as phenylketonuria.
• Critical illness nutrition: Contributes to meeting protein targets in intensive care patients.
• Malnutrition and cachexia: Aids in restoring lean body mass during prolonged catabolic states.

• The amino acid blend in Olimel N7e supplies substrates for protein synthesis, stimulates the mTOR signaling pathway and supports nitrogen balance. By providing essential building blocks, it facilitates tissue repair, enzyme production and neurotransmitter synthesis, while modulating metabolic responses during catabolic stress.

Adverse reactions to amino acid mixtures are generally mild and related to gastrointestinal tolerance.

Common Side Effects

• Nausea: mild, transient upset stomach.
• Diarrhea: loose stools, often resolves with continued use.
• Abdominal discomfort: cramping or bloating.
• Metallic taste: temporary alteration of taste perception.
• Headache: mild, non‑specific.

Serious or Rare Side Effects

• Hyperammonemia: elevated blood ammonia levels, particularly in severe liver disease.
• Allergic reaction: rash, itching, swelling, or anaphylaxis.
• Metabolic acidosis: rare disturbance of acid‑base balance.
• Hyperkalemia: elevated potassium levels in susceptible patients.
• Severe gastrointestinal bleeding: uncommon but serious.
• Electrolyte imbalance: abnormal serum levels of sodium, calcium or magnesium.

When using Olimel N7e, consider patient‑specific factors and monitor relevant clinical parameters.

• Renal impairment: adjust dosage and monitor serum electrolytes.
• Hepatic dysfunction: watch for signs of hyperammonemia.
• Pregnancy and lactation: limited data, use only if clearly needed.
• Pediatric use: dosing must be individualized by a specialist.
• Concomitant nutrition therapy: avoid excessive protein intake.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Amino acid mixtures can influence the absorption and metabolism of several drug classes.

Major Interactions (Avoid)

• Levodopa: reduced absorption leading to diminished therapeutic effect.
• MAO‑inhibitors: risk of hypertensive crisis due to tyramine content.
• Thyroid hormone replacement: interference with absorption, requiring dose adjustment.

Moderate Interactions (Monitor Closely)

• Anticonvulsants (e.g., valproate): possible alteration of plasma amino‑acid levels.
• Antibiotics (e.g., tetracycline): chelation reducing oral bioavailability.
• Diuretics: potential electrolyte disturbances requiring monitoring.